1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 33

    Cigar wrapper production in Zimbabwe: an overview of past, present and future prospects

    MUKOYI F.(1); MAGAMA F.(1); EDMONDSON A.(2); GUILD L.(3); GARWE D.(1)
    (1) Tobacco Research Board, Harare, Zimbabwe; (2) Von Eicken, Lübeck, Germany; (3) Mapeto Farm, Burma Valley, Zimbabwe
    The cigar wrapper tobacco type was once grown in Zimbabwe in the early 1950s in a project that was championed by British American Tobacco (BAT). However, production was stifled owing to viability challenges coupled with loss of interest from growers. ...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 03

    The effect of socio-economic inequalities: modelling of population health impact of introducing reduced-risk tobacco products into Germany

    RYTSAR R.(1); DJURDJEVIC S.(1); NUSSBAUM A.(2); KAUL A.(3,4); BENNEWITZ E.(3,4)
    (1) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) Philip Morris GmbH, Gräfelfing, Germany; (3) Saarland University, Department of Economics, Saarbrücken, Germany; (4) IPE Institute for Policy Evaluation, Frankfurt, Germany
    Education, income and occupation are the most commonly used descriptors of social inequalities in health. The socio-economic status (SES) of individuals (or groups of individuals) has proven to be important when describing and understanding smoking ...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 09

    The ABOUT™ Toolbox: toward the development of consumer-reported outcome measures that matter

    CHREA C.(1); SPIES E.(1); AFOLALU E.(1); BACSO A.(1); CLERC E.(1); MAINY N.(1); BINGGELI P.(1); WEITKUNAT R.(1); ACQUADRO C.(2); SALZBERGER T.(3); CANO S.(4); ABETZ-WEBB L.(5); ROSE J.(6)
    (1) PMI R&D, Philip Morris Products S.A., Neuchatel, Switzerland; (2) Mapi, an ICON plc Company, Lyon, France; (3) University of Economics and Business, Vienna, Austria; (4) ScaleReport, Ltd, Stotfold, U.K.; (5) Patient-Centered Outcomes Assessments, Ltd, Macclesfield Cheshire, U.K.; (6) Rose Research Center, Raleigh, U.S.A.
    Tobacco harm reduction promotes the substitution of reduced-risk products (RRPs) for cigarettes by adult smokers who would otherwise continue to smoke, while preventing RRP initiation among non-users. To operationalize this public health strategy, there ...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 11

    Development and validation of the ABOUT™–Dependence measurement instrument to assess perceived dependence on tobacco and nicotine products

    AFOLALU E.(1); CHREA C.(1); SALZBERGER T.(2); ABETZ-WEBB L.(3); CANO S.(4); WEITKUNAT R.(1); ROSE J.(5)
    (1) PMI R&D, Philip Morris Products S.A., Neuchatel, Switzerland; (2) University of Economics and Business, Vienna, Austria; (3) Patient-Centered Outcomes Assessments, Ltd, Macclesfield Cheshire, U.K.; (4) Modus Outcomes, Letchworth Garden City, U.K.; (5) Rose Research Center, Raleigh, U.S.A.
    The development of the ABOUT™–Dependence measurement instrument was initiated to enable assessment of perceived dependence associated with the use of different tobacco and nicotine products (TNPs) and in users of multiple TNPs. We initially developed a ...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 23 (also presented at TSRC 2019)

    Functional filter plug wrap paper for control of the thermal energy of the aerosol from heated tobacco products (HTPs)

    LINDNER M.; LEICHSENRING N.
    (1) TANNPAPIER GmbH, Traun, Austria; (2) Hauni Maschinenbau GmbH, Hamburg, Germany
    Next generation products, which include all kinds of e-vapour items as well as heated tobacco products (HTPs or “heat sticks”), have successfully entered the tobacco market in addition to conventionally combustible cigarettes. From the basic geometrical ...
  6. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 29

    Thermochemical and thermophysical mapping of burning superslim and kingsize cigarettes

    EHLERT S.(1,3); CUI H.(2); HEIDE J.(3); XIE F.(2); DENG N.(2); LIU C.(4); McADAM K.(4); WALTE A.(1); ZIMMERMANN R.(3)
    (1) Photonion GmbH, Schwerin, Germany; (2) Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, P.R. China; (3) University of Rostock, Dept. of Analytical Chemistry, Rostock, Germany; (4) British American Tobacco, R&D Centre, Southampton, U.K.
    After presenting and publishing the proof of principle of the in-situ thermochemical and thermophysical mapping inside a burning Super Slim (SS) cigarette, we now extended the study scope to other cigarette formats and smoking regimes [1]. A Chinese ...
  7. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 34

    E-cigarette data standards and open platform architecture for risk and compliance management, supply chain optimization, and real-time benchmarking

    CAPONE M.J.
    HAUNI Maschinenbau GmbH, Hamburg, Germany
    InIn the next few years, the digital maturity of the e-cigarette sector will evolve offline electronic devices to products that connect via a communication device such as a smart phone or router, and ultimately to Internet-of-Things (IoT)-enabled products ...
  8. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 39

    The mechanism of evaporation in conventional wick-and-coil e-cigarettes compared to an alternative volumetric heater approach

    SCHMIDT R.; KESSLER M.
    HAUNI Maschinenbau GmbH, Hamburg, Germany
    Conventional electronic cigarettes facilitate the so called wick-and-coil-systems for liquid evaporation. This technology shows essential drawbacks inherent to the system. Due to the non-uniform temperature distribution throughout the heated volume there ...
  9. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 53

    NNN – a suitable biomarker of exposure from smoke and new nicotine delivery products?

    PLUYM N.; TAUCHER J.; SCHERER G.; SCHERER M.
    ABF Analytisch-Biologisches Forschungslabor GmbH, Planegg, Germany
    N-Nitrosonornicotine (NNN) is believed to play a critical role in the development of cancer in tobacco users and was therefore classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen. Hence, urinary NNN is commonly ...